Register for a Zenrelia™ discovery session
How Zenrelia can help your patients
Led by an Elanco veterinary technical expert, our discovery sessions are available either live online or as a pre-recorded option. This is an information-packed 45 minutes on how Zenrelia can help you get more itchy dogs in your practice back to normal1 **
You’ll hear about a selection of success stories from over 1 million dogs worldwide with atopic and allergic dermatitis treated with Zenrelia2.
To listen to a discovery session, either live or pre-recorded, you’ll need to register first. It will only take a couple of minutes. Then you’re all set to learn more about Zenrelia’s effective, continuous itch relief.
You’ll receive information on how to prescribe Zenrelia for the itchy dogs in your practice, including:
Current perspectives on dermatology
How Zenrelia works to provide itch relief
Simple dosing, safety profile and pricing
Zenrelia Wins New Product of the Year!
Zenrelia™ has been awarded New Product of the Year at the recent Veterinary Marketing Awards (VMAs) as voted for by UK vets, reflecting its popularity in the UK and impact in the management of canine allergic and atopic dermatitis. Zenrelia also received several other awards at the VMAs, including the Exhibition Award for creating a stand-out space at London Vet Show.
Find out more about the success of Zenrelia at the VMA's here:
Further questions?
Additional Resources
*Referenceable claims in digital and social copy can be found on this page. Full reference list below.
**A 'normal' itch score is considered to be comparable to that of a healthy, non-allergic dog (PVAS <2).1
- Forster S et al. Vet Dermatol. 2025 Apr;36(2):165–76.
- Elanco Global Sales Data December 2025
